Major apolipoprotein B-100 mutations in lipoprotein metabolism and atherosclerosis

Physiological Research

Volumn 50, Issue 4, 2001, Pages 337-343

  Vrablik M ^a   Ceska R ^a   Horinek A ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Apolipoprotein B 100; Atherosclerosis; Hyperlipidemia; Mutations

Indexed keywords

APOLIPOPROTEIN B100; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

AMINO ACID SUBSTITUTION; ATHEROSCLEROSIS; BINDING AFFINITY; BINDING SITE; GENE MUTATION; HUMAN; HYPERLIPIDEMIA; LIPOPROTEIN METABOLISM; MOLECULAR BIOLOGY; NONHUMAN; PROTEIN BINDING; PROTEIN STRUCTURE; PROTEIN VARIANT; SHORT SURVEY;

APOLIPOPROTEIN B-100; APOLIPOPROTEINS B; ARTERIOSCLEROSIS; HUMANS; HYPERLIPIDEMIAS; MUTATION;

EID: 0034845715     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (44)

1. Structure of the human apolipoprotein B gene
2. Familial defective apolipoprotein B-100 and myocardial infarction. The ECTIM study
3. A receptor mediated pathway for cholesterol homeostasis
4. Denaturing gradient gel electrophoresis screening of familial defective apolipoprotein B-100 in a mixed Asian cohort: Two cases of arginine3500→tryptophan mutation associated with a unique haplotype
5. The complete sequence and structural analysis of human apolipoprotein B-100: Relationship between apoB-100 and apoB-48
6. Familial defective apolipoprotein B-100: A lesson from homozygous and heterozygous patients
7. Genetic evidence that the putative binding domain of apolipoprotein B (residues 3130-3630) is not the only region of the protein involved in interaction with the low density lipoprotein receptor
8. Molecular weights of apoprotein B obtained from human low-density lipoprotein (apoprotein B-PI) and from rat very low density lipoprotein (apoprotein B-PIII)
9. Apolipoprotein B gene mutations in Austrian subjects with heart disease and their kindred
10. Homozygosity for familial defective apolipoprotein B-100 is associated with lower plasma cholesterol than homozygosity for familial hypercholesterolemia
11. Independent mutations at codon 3500 of the apolipoprotein B gene are associated with hyperlipidemia
12. The affinity of LDL and VLDL remnants for the LDL receptor in homozygous familial defective apolipoprotein B-100
13. Absence of familial defective apolpoprotein B-100 in Finnish patients with elevated serum cholesterol
14. Structure and metabolism of plasma lipoproteins
15. Apolipoproteins and atherosclerosis. Apolipoprotein E and apolipoprotein (a) as candidate genes of premature development of atherosclerosis
16. Hypocholesterolemic effects of lovastatin in familial defective apolipoprotein B-100
17. Familial defective apolipoprotein B100: Low density lipoproteins with abnormal receptor binding
18. Isolation of defective receptor-binding low density lipoproteins from subjects with familial defective apolipoprotein B-100
19. Familial defective apolipoprotein B-100: A mutation of apolipoprotein B that causes hypercholesterolemia
20. Haplotype analysis of the human apolipoprotein B mutation associated with familial defective apolipoprotein B 100
21. Association of genetic variations in apolipoprotein B with hypercholesterolemia, coronary artery disease and receptor binding of low density lipoproteins
22. 13C NMR evidence that substitution of Gln for Arg 3500 in FDB-100 disrupts the conformation of the receptor binding domain
23. The binding affinity of very low density lipoprotein remnants to the low density receptor in FDB-100
24. Does the presence of the 3500 mutant apolipoprotein B-100 in low density lipoprotein particles affect their atherogenicity?
25. Accumulation of "small dense" low density lipoproteins (LDL) in a homozygous patient with familial defective apolipoprotein B-100 results from heterogeneous interaction of LDL subfractions with the LDL receptor
26. Differences in the phenotypic characteristics of subjects with familial defective apolipoprotein B-100 and familial hypercholesterolemia
27. High prevalence of familial defective apolipoprotein B-100 in Switzerland
28. Estimation of the age of the ancestral arginine 3500→glutamine mutation in human apoB-100
29. Discrete subspecies of human low density lipoproteins are heterogeneous in their interaction with the cellular LDL receptor
30. Possible functional interactions of apolipoprotein B-100 segments that associate with cell proteoglycans and the apoB/E receptor
31. The apolipoprotein B R3531C mutation: Characteristics of 24 subjects from 9 kindreds
32. Familial ligand-defective apolipoprotein B100: Simultaneous detection of the Arg3500Gln and Arg3531Cys mutations in a French population
33. Human apolipoprotein E. The complete amino acid sequence
34. Familal defective apolipoprotein B-100: Haplotype analysis of the arginine 3500→ glutamine mutation
35. Homozygous familial defective apolipoprotein B-100. Enhanced removal of apolipoprotein E-containing VLDLs and decreased production of LDLs
36. Apolipoprotein B and low-density lipoprotein structure: Implications for biosynthesis of triglyceride-rich lipoproteins
37. Familial defective apolipoprotein B-100. Comparison with familial hypercholesterolemia in eighteen cases detected in Munich
38. Identification and haplotype analysis of apolipoprotein B-100 Arg3500→Trp mutation in hyperlipidemic Chinese
39. Familial defective apolipoprotein B-100: Detection in the United Kingdom and Scandinavia, and clinical characteristics of ten cases
40. Association of mutations in the apolipoprotein B gene with hypercholesterolemia and the risk of ischemic heart disease
41. Screening for familial defective apoliporotein B-100 with improved U937 monocyte proliferation assay
42. Lipoproteins containing apolipoprotein B-100 are secreted by the heart
43. Familial defective appolipoprotein B-100: Enhanced binding of monoclonal antibody MB 47 to abnormal low density lipoproteins
44. Familial ligand-defective apolipoprotein B-100: Detection, biochemical features and haplotype analysis of the R3531C mutation in the UK